Fate Therapeutics (FATE) FCF Margin Growth (5y) (2017 - 2026)
Fate Therapeutics (FATE) FCF Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -212,441.00 |
| Dec 31, 2025 | -196,448.00 |
| Sep 30, 2025 | -92,628.00 |
| Jun 30, 2025 | -203,418.00 |
| Mar 31, 2025 | -101,255.00 |
| Dec 31, 2024 | -49,749.00 |
| Sep 30, 2024 | -8,434.00 |
| Jun 30, 2024 | 31,517.00 |
| Mar 31, 2024 | -101,226.00 |
| Dec 31, 2023 | -181,237.00 |
| Sep 30, 2023 | -128,213.00 |
| Jun 30, 2023 | -214,053.00 |
| Mar 31, 2023 | 118,686.00 |
| Dec 31, 2022 | 101,431.00 |
| Sep 30, 2022 | 56,207.00 |
| Jun 30, 2022 | 52,742.00 |
| Mar 31, 2022 | 37,176.00 |
| Dec 31, 2021 | 5,149.00 |
| Sep 30, 2021 | 59,941.00 |
| Jun 30, 2021 | 39,969.00 |